Digital gamma camera developer Digirad of San Diego announced this month that it has signed a distribution and service agreement with National Imaging Resources for its Digirad 2020 TC Imager. Birmingham, AL-based NIR will gain U.S. distribution rights
Digital gamma camera developer Digirad of San Diego announced this month that it has signed a distribution and service agreement with National Imaging Resources for its Digirad 2020 TC Imager. Birmingham, AL-based NIR will gain U.S. distribution rights to the system, which uses solid-state detectors made from cadmium zinc telluride.
The agreement gives Digirad access to a strong sales structure it has not had before: NIR boasts 190 sales representatives, a 400-member service organization, and a regional network consisting of more than 50 locations. But NIR also expects to benefit from the deal, gaining access to the nuclear medicine market. NIR reports annual sales of more than $500 million.
The deal further strengthens Digirad's market position, especially in light of patents the company received last month that cover a method of manufacturing solid-state digital detector modules (SCAN 10/28/98). Digirad 2020 TC Imager was cleared by the Food and Drug Administration in June 1997 (SCAN 6/11/97).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.